Jen Smith

The median relapse-free survival from the start of dabrafenib and trametinib treatment was 18.9 months.

The incidence of cutaneous melanoma is generally declining among pediatric and adolescent and young adult (AYA) patients in the United States, according to research published in the Journal of the American Academy of Dermatology

BCMA-directed chimeric antigen receptor (CAR) T-cell therapy may be less effective in patients with multiple myeloma (MM) who have previously received high-dose melphalan and an autologous stem cell transplant (HDM/ASCT), a new study suggests.

A large study suggests that pediatric cancer patients are more likely to die in the hospital than at home. The data showed that 52% of patients died in the hospital, and 40% died at home. These findings were published in JAMA Pediatrics.

BONUS: Frugal Ain't Cheap | Jen & Jill x How To Money Podcast Today's episode offers a peek into what your favorite personal finance podcast might be like, if only it was hosted by two ladies!

Cancer care in prisons is logistically complicated, and incarcerated patients encounter barriers to optimal cancer care, according to a presentation at the 2024 ASCO Quality Care Symposium. 1

Drinking more than 4 cups of caffeinated coffee daily was associated with a lower risk of oral cavity and oropharyngeal cancers regardless of a person’s age, sex, smoking and alcohol consumption, and other factors.

The COVID-19 pandemic led to declines in 1-year survival and an increased risk of death from both cancer and non-cancer causes.

Researchers found a significant association between advanced breast cancer and cardiovascular disease among patients with hormone receptor-positive breast cancer.

The restricted mean leukemia-free survival up to 5 years was longer among patients who received an allogeneic transplant than among patients who received another type of consolidation therapy.